Rapid Micro Biosystems Inc
NASDAQ:RPID
Rapid Micro Biosystems Inc
NASDAQ:RPID
Price:
2.12
USD
Market Closed
Market Cap:
$94m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Rapid Micro Biosystems Inc
NASDAQ:RPID
|
US |
|
Eurasia Fonciere Investissements SA
PAR:EFI
|
FR |
|
C
|
China Banking Corp
XPHS:CHIB
|
PH |
|
BioNexus Gene Lab Corp
NASDAQ:BGLC
|
MY |
|
EQUUS Total Return Inc
NYSE:EQS
|
US |
|
S
|
Swedencare AB (publ)
STO:SECARE
|
SE |
Balance Sheet
Balance Sheet Decomposition
Rapid Micro Biosystems Inc
Rapid Micro Biosystems Inc
Balance Sheet Decomposition is not available for
Rapid Micro Biosystems Inc
Rapid Micro Biosystems Inc
Balance Sheet
Rapid Micro Biosystems Inc
Rapid Micro Biosystems Inc
Currency: USD
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
13
|
30
|
178
|
27
|
24
|
17
|
20
|
|
| Cash Equivalents |
13
|
30
|
178
|
27
|
24
|
17
|
20
|
|
| Short-Term Investments |
0
|
15
|
15
|
82
|
68
|
34
|
18
|
|
| Total Receivables |
5
|
6
|
6
|
6
|
6
|
8
|
3
|
|
| Accounts Receivables |
4
|
6
|
5
|
6
|
6
|
8
|
3
|
|
| Other Receivables |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
6
|
9
|
16
|
21
|
20
|
20
|
18
|
|
| Other Current Assets |
1
|
2
|
3
|
3
|
3
|
2
|
2
|
|
| Total Current Assets |
24
|
62
|
218
|
139
|
120
|
81
|
61
|
|
| PP&E Net |
8
|
7
|
11
|
21
|
19
|
16
|
13
|
|
| PP&E Gross |
8
|
7
|
11
|
21
|
19
|
16
|
13
|
|
| Accumulated Depreciation |
9
|
10
|
12
|
12
|
14
|
17
|
20
|
|
| Long-Term Investments |
0
|
0
|
10
|
30
|
3
|
0
|
0
|
|
| Other Long-Term Assets |
1
|
1
|
2
|
1
|
1
|
1
|
1
|
|
| Total Assets |
32
N/A
|
70
+121%
|
241
+245%
|
191
-21%
|
143
-25%
|
98
-32%
|
75
-24%
|
|
| Liabilities | ||||||||
| Accounts Payable |
3
|
5
|
4
|
5
|
2
|
3
|
4
|
|
| Accrued Liabilities |
5
|
6
|
10
|
8
|
11
|
8
|
10
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
2
|
5
|
4
|
5
|
6
|
7
|
5
|
|
| Total Current Liabilities |
11
|
16
|
18
|
19
|
19
|
18
|
18
|
|
| Long-Term Debt |
18
|
25
|
0
|
0
|
0
|
0
|
19
|
|
| Other Liabilities |
4
|
5
|
2
|
7
|
6
|
5
|
4
|
|
| Total Liabilities |
32
N/A
|
45
+40%
|
20
-55%
|
27
+31%
|
25
-4%
|
23
-10%
|
42
+83%
|
|
| Equity | ||||||||
| Common Stock |
82
|
152
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
205
|
242
|
315
|
376
|
428
|
475
|
522
|
|
| Additional Paid In Capital |
122
|
115
|
536
|
541
|
546
|
550
|
555
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Total Equity |
1
N/A
|
25
N/A
|
221
+791%
|
164
-26%
|
118
-28%
|
75
-36%
|
33
-56%
|
|
| Total Liabilities & Equity |
32
N/A
|
70
+121%
|
241
+245%
|
191
-21%
|
143
-25%
|
98
-32%
|
75
-24%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
40
|
40
|
42
|
42
|
42
|
43
|
45
|
|
Switch to:
Switch to:
See Also
Discover More
